利用RCAS-PDGFB驱动胶质瘤的正向遗传筛选发现新癌症基因
研究采用RCAS-TVA小鼠肿瘤模型结合高通量测序,在RCAS-PDGFB驱动的胶质瘤活检来源恶性干细胞系中可重复检测到逆转录病毒整合位点。整合位点富集胶质瘤相关失调基因,并发现Ppfibp1为频繁标记的新候选致癌基因;人胶质瘤中PPFIBP1表达升高与不良预后及PDGF治疗耐药显著相关。
要点
- RCAS-PDGFB驱动胶质瘤模型中可重复检测逆转录病毒整合位点。
- Ppfibp1被鉴定为频繁标记的候选胶质瘤致癌基因。
- 人胶质瘤中PPFIBP1高表达与不良预后及PDGF治疗耐药显著相关。
核心结论
- 研究证明通过正向遗传学标记胶质瘤基因的新方法,验证了既往结果,并将PPFIBP1鉴定为胶质瘤发生中的候选致癌基因。
研究设计与样本
- 研究采用高通量流程结合常用的组织特异性逆转录病毒RCAS-TVA小鼠肿瘤模型系统,并利用下一代测序进行分析。
主要发现
- 在RCAS-PDGFB驱动的胶质瘤活检来源恶性干细胞系中可重复检测到逆转录病毒整合位点。
- 大部分常见整合位点所含基因在胶质瘤中失调或错误表达,部分与既往胶质瘤正向遗传筛选鉴定的位点重叠,并发现若干新候选致癌基因。
- Ppfibp1被突出为频繁标记的新胶质瘤致癌基因,逆转录病毒整合入该位点导致Ppfibp1上调。
- Ppfibp1标记细胞在原位移植后生成肿瘤的潜伏期更短。
- 人胶质瘤中PPFIBP1表达升高与不良预后及PDGF治疗耐药显著相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Malignant gliomas, the most common malignant brain tumors in adults, represent a heterogeneous group of diseases with poor prognosis. Retroviruses can cause permanent genetic alterations that modify genes close to the viral integration site. METHODS: Here we describe the use of a high-throughput pipeline coupled to the commonly used tissue-specific retroviral RCAS-TVA mouse tumor model system. Utilizing next-generation sequencing, we show that retroviral integration sites can be reproducibly detected in malignant stem cell lines generated from RCAS-PDGFB-driven glioma biopsies. RESULTS: A large fraction of common integration sites contained genes that have been dysregulated or misexpressed in glioma. Others overlapped with loci identified in previous glioma-related forward genetic screens, but several novel putative cancer-causing genes were also found. Integrating retroviral tagging and clinical data, Ppfibp1 was highlighted as a frequently tagged novel glioma-causing gene. Retroviral integrations into the locus resulted in Ppfibp1 upregulation, and Ppfibp1-tagged cells generated tumors with shorter latency on orthotopic transplantation. In human gliomas, increased PPFIBP1 expression was significantly linked to poor prognosis and PDGF treatment resistance. CONCLUSIONS: Altogether, the current study has demonstrated a novel approach to tagging glioma genes via forward genetics, validating previous results, and identifying PPFIBP1 as a putative oncogene in gliomagenesis.
引用
- Weishaupt H, Čančer M, Rosén G, et al. Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas. Neuro Oncol. 2023. PMID: 35738865. doi:10.1093/neuonc/noac158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。